Salubris Pharmaceuticals invested $10m to lead a NantKwest-backed round as part of a Chinese licensing agreement for Viracta's herpes therapies.

Alberta-founded renewable fuel producer Forge Hydrocarbons hopes its lipids-based fuels will provide a cleaner alternative to petrol.

The parking app developer has lined up SoftBank as lead investor in a round in which it is looking to raise $800m to $1bn, with Mubadala Investment also set to take part.

Kidney disease drug developer Variant has raised $10m from new strategic partner Incon in connection with a distribution agreement.

IP Group and its Venture Fund II have pumped more cash into Bristol's haptics technology developer Ultrahaptics to take the spinout’s total to $84.3m.

The ride hailing app is in advanced talks to invest $100m in the round which includes contribution from SoftBank Vision Fund and values the hotel operator at $5bn.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

University of Twente-founded MyLife Technologies will commercialise a microneedle-based dermal patch for administering therapeutic compounds.

Loyalty Prime has been backed by the VC affiliate of Technical University of Munich’s Unternehmertum as it builds the international profile of its loyalty scheme management software.

Mitsubishi Chemical Holdings and Niantic have joined a series C round for DigiLens that stood at $25m as of May this year and already included Continental.